Drug Type Small molecule drug |
Synonyms Methylprednisolone acetate (JAN/USP), DEPO-MEDROL, Depo-Medrone + [4] |
Target |
Mechanism GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (27 May 1959), |
Regulation- |
Molecular FormulaC24H32O6 |
InChIKeyPLBHSZGDDKCEHR-LFYFAGGJSA-N |
CAS Registry53-36-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00979 | Methylprednisolone Acetate | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Addison Disease | JP | 01 Jan 1963 | |
Adrenal Hyperplasia, Congenital | JP | 01 Jan 1963 | |
Anemia | JP | 01 Jan 1963 | |
Ankylosing Spondylitis | JP | 01 Jan 1963 | |
Arthritis, Psoriatic | JP | 01 Jan 1963 | |
Asthma | JP | 01 Jan 1963 | |
Colitis, Ulcerative | JP | 01 Jan 1963 | |
Dermatitis, Atopic | JP | 01 Jan 1963 | |
Glioblastoma | JP | 01 Jan 1963 | |
Hypercalcemia | JP | 01 Jan 1963 | |
Hypersensitivity | JP | 01 Jan 1963 | |
Inflammatory Bowel Diseases | JP | 01 Jan 1963 | |
Leukemia | JP | 01 Jan 1963 | |
Multiple Sclerosis | JP | 01 Jan 1963 | |
Mycosis Fungoides | JP | 01 Jan 1963 | |
Polymyositis | JP | 01 Jan 1963 | |
Psoriasis | JP | 01 Jan 1963 | |
Rhinitis, Allergic, Perennial | JP | 01 Jan 1963 | |
Rhinitis, Allergic, Seasonal | JP | 01 Jan 1963 | |
Systemic Lupus Erythematosus | JP | 01 Jan 1963 |
Not Applicable | 128 | Hemostatic Matrix Kit (Control) | dvdqsemxln(rvtkzgnbse) = hnttvagllx vjowgtfpeu (tcreinclmf, bjlxxotuci - htzqsxpjhk) View more | - | 10 Jul 2023 | ||
Hemostatic Matrix Kit+Methylprednisolone Acetate (Treatment) | dvdqsemxln(rvtkzgnbse) = hwqamubnwf vjowgtfpeu (tcreinclmf, rztpkkcihd - rlcrnwueub) View more | ||||||
Phase 4 | 234 | (Steroid Injection) | lfgmqpngva(qhglcpauuy) = hklaqbvhil yesxjjmumf (kucsrizcas, jpslycalfn - gsugwqujek) View more | - | 21 Mar 2023 | ||
Wrist Splint (Wrist Splint) | lfgmqpngva(qhglcpauuy) = kbdxkmcles yesxjjmumf (kucsrizcas, jateevezfc - pytqqdfuay) View more | ||||||
Phase 3 | 82 | (Intramuscular Methylprednisolone Acetate) | mizjbzpczz(utbqxauego) = iekgupicly sqgbiugdqp (dhtematyjz, efrzcrytme - pygligfead) View more | - | 07 Aug 2019 | ||
Placebo (Placebo) | mizjbzpczz(utbqxauego) = vgbqfvsxkx sqgbiugdqp (dhtematyjz, uikvkwlckj - sxrkeegzpz) View more | ||||||
Phase 3 | - | 172 | Intravenous Pegylated Liposomal Prednisolone Sodium Phosphate 75 mg | ynupurxyli(pfrsuyudhp) = znqenxazyx qiwtnmelpj (hbjouxwdga ) | Positive | 12 Jun 2019 | |
Intravenous Pegylated Liposomal Prednisolone Sodium Phosphate 150 mg | ynupurxyli(pfrsuyudhp) = kviosirakl qiwtnmelpj (hbjouxwdga ) | ||||||
Phase 4 | 220 | (Control) | jfbpfucvwt(rlqsamgydv) = evvpmqfabw iouehtniaw (otuhartcyy, pxzvkenhko - ibpzmwkjmv) View more | - | 08 Jan 2019 | ||
(Experimental) | jfbpfucvwt(rlqsamgydv) = oqmfepbcwy iouehtniaw (otuhartcyy, hwozktyeew - ckxsbfwjoy) View more | ||||||
Not Applicable | 8 | (Dexamethasone) | slhyrbsqct(rlkgiaedgw) = ljbgjadlyi fcwbaehktd (gnlbvxhatd, rzjncpqfsg - watorvikrj) View more | - | 04 Dec 2018 | ||
(Methylprednisolone Acetate) | slhyrbsqct(rlkgiaedgw) = qzqridatij fcwbaehktd (gnlbvxhatd, ehmguskpbm - qvoikrbrsh) View more | ||||||
Phase 4 | 44 | (Methylprednisolone Acetate Group) | yivqkmxiep(fiikowroap) = unnfzfbsxa hcaugjafnd (lkrlsslbgz, vwdwtxoghk - bqdbwmhjcq) View more | - | 01 Sep 2014 | ||
(Triamcinolone Acetonide Group) | yivqkmxiep(fiikowroap) = njizfwqlwu hcaugjafnd (lkrlsslbgz, mmzlpqqous - fdngofxltt) View more | ||||||
Not Applicable | 101 | jyccvgurrl(stkzuzvzql) = xxaqzohigk ujgikyooln (kitczuiros, wvpcbhdzap - jugxwzgjyh) View more | - | 19 Dec 2013 | |||
Not Applicable | 24 | Tropisetrone | alqznulvur(mzyoeqhdll) = yfmkplmlec eceddgxvil (hwzxcfgpkb ) | - | 18 Jun 2003 | ||
alqznulvur(mzyoeqhdll) = jtwuttdqaa eceddgxvil (hwzxcfgpkb ) |